A carregar...
Optimizing complement-activating antibody-based cancer immunotherapy: a feasible strategy?
Passive immunotherapy with monoclonal antibodies (mAb) targeted to specific tumor-associated antigens is amongst the most rapidly expanding approaches to biological therapy of cancer. However, until now a limited number of therapeutic mAb has demonstrated clinical efficacy in selected neoplasia. Res...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2004
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC455694/ https://ncbi.nlm.nih.gov/pubmed/15219237 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-2-21 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|